Just reported that in the last 2 weeks of January the shorts added 900,000 new shares to their short position. That means they are net shorting 100,000 shares each trading day. That is a lot of selling pressure on the stock. Will they stay short hoping to make $1.50 per share with a risk of losing $15 per share if Allovectin has good phase 3 results?
If I posted it 3 times I've posted it 10 times.I have been investing for 45 years and have owned AMGN the entire time...I have never seen a more targeted effort by shorts in my long life.Never.I agree with most here, one announcement and they are done.I'm sure its coming.Dont give away your stock down here, they just did a raise that means we're good.